The Research Base

Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis

Psychedelic Therapy—A New Paradigm of Care for Mental Health | Psychiatry and Behavioral Health | JAMA | JAMA Network

Ketamine for teh treatment of mental health and substance-use disorders

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study | Nature Medicine

The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.

Trial of Psilocybin versus Escitalopram for Depression | New England Journal of Medicine (nejm.org)

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics

The Potential Synergistic Effects Between Psychedelic Administration and Nature Contact for the Improvement of Mental Health

“Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance”

“Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial”

“Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction”.

Disclaimer:

*The Ouroboros Foundation does not advocate for the illegal use of psychoactive substances. All information provided on this website is intended solely for educational purposes and harm reduction. Our mission is to support modern mental health research and promote safe, informed practices. Please consult with a healthcare professional before making any decisions related to your mental health and well-being.